{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:38:27Z","timestamp":1781624307075,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11882-024-01179-1","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:06:21Z","timestamp":1726049181000},"page":"651-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis"],"prefix":"10.1007","volume":"24","author":[{"given":"Matthew P.","family":"Giannetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"4","key":"1179_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","volume":"145","author":"MS Shaker","year":"2020","unstructured":"Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082\u2013123. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.017.","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR2","doi-asserted-by":"publisher","unstructured":"Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Annals of Allergy, Asthma & Immunology 2023. https:\/\/doi.org\/10.1016\/j.anai.2023.09.015.","DOI":"10.1016\/j.anai.2023.09.015"},{"issue":"5","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaci.2020.08.015","volume":"146","author":"TE Dribin","year":"2020","unstructured":"Dribin TE, Sampson HA, Camargo CA, et al. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. J Allergy Clin Immunol. 2020;146(5):1089\u201396. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.015.","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR4","first-page":"151","volume":"53","author":"V Popa","year":"1984","unstructured":"Popa V, Lerner S. Biphasic systemic anaphylactic reactions: three illustrative cases. Ann Allergy. 1984;53:151\u20135.","journal-title":"Ann Allergy"},{"key":"1179_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0091-6749(86)90117-X","volume":"78","author":"B Stark","year":"1986","unstructured":"Stark B, Sullivan T. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76\u201383.","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1081-1206(10)61217-3","volume":"95","author":"P Lieberman","year":"2005","unstructured":"Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95:217\u201326.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1179_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","volume":"47","author":"HA Sampson","year":"2006","unstructured":"Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report - Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network Symposium. Ann Emerg Med. 2006;47(4):373\u201380. https:\/\/doi.org\/10.1016\/j.annemergmed.2006.01.018.","journal-title":"Ann Emerg Med"},{"key":"1179_CR8","doi-asserted-by":"publisher","unstructured":"Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organization Journal 2020;13(10). https:\/\/doi.org\/10.1016\/j.waojou.2020.100472.","DOI":"10.1016\/j.waojou.2020.100472"},{"issue":"2","key":"1179_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","volume":"114","author":"SGA Brown","year":"2004","unstructured":"Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2004.04.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","volume":"26","author":"J Ring","year":"1977","unstructured":"Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;26:466\u20139.","journal-title":"Lancet"},{"issue":"15","key":"1179_CR11","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","volume":"41","author":"MS Gold","year":"2023","unstructured":"Gold MS, Amarasinghe A, Greenhawt M, et al. Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine. 2023;41(15):2605\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.027.","journal-title":"Vaccine"},{"issue":"2","key":"1179_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","volume":"132","author":"DBK Golden","year":"2024","unstructured":"Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124\u201376. https:\/\/doi.org\/10.1016\/j.anai.2023.09.015.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1179_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/aci.0000000000000279","volume":"16","author":"S Lee","year":"2016","unstructured":"Lee S, Sadosty AT, Campbell RL. Update on biphasic anaphylaxis. Curr Opin Allergy Clin Immunol. 2016;16(4):346\u201351. https:\/\/doi.org\/10.1097\/aci.0000000000000279.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"1179_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.anai.2015.05.013","volume":"115","author":"W Alqurashi","year":"2015","unstructured":"Alqurashi W, Stiell I, Chan K, Neto G, Alsadoon A, Wells G. Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis. Ann Allergy Asthma Immunol. 2015;115(3):217-223.e2. https:\/\/doi.org\/10.1016\/j.anai.2015.05.013.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"1179_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jaip.2017.07.020","volume":"5","author":"S Lee","year":"2017","unstructured":"Lee S, Peterson A, Lohse CM, Hess EP, Campbell RL. Further Evaluation of Factors That May Predict Biphasic Reactions in Emergency Department Anaphylaxis Patients. J Allergy Clin Immunol In Practice. 2017;5(5):1295\u2013301. https:\/\/doi.org\/10.1016\/j.jaip.2017.07.020.","journal-title":"J Allergy Clin Immunol In Practice"},{"issue":"6","key":"1179_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.annemergmed.2013.10.017","volume":"63","author":"BE Grunau","year":"2014","unstructured":"Grunau BE, Li J, Yi TW, et al. Incidence of Clinically Important Biphasic Reactions in Emergency Department Patients With Allergic Reactions or Anaphylaxis. Ann Emerg Med. 2014;63(6):736-744.e2. https:\/\/doi.org\/10.1016\/j.annemergmed.2013.10.017.","journal-title":"Ann Emerg Med"},{"key":"1179_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejim.2022.03.003","volume":"100","author":"CM Rossi","year":"2022","unstructured":"Rossi CM, Lenti MV, Di Sabatino A. Adult anaphylaxis: A state-of-the-art review. Eur J Intern Med. 2022;100:5\u201312. https:\/\/doi.org\/10.1016\/j.ejim.2022.03.003.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1179_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","volume":"115","author":"P Lieberman","year":"2015","unstructured":"Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis\u2014a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341\u201384. https:\/\/doi.org\/10.1016\/j.anai.2015.07.019.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1179_CR19","doi-asserted-by":"publisher","unstructured":"Moon TC, Dean Befus A, Kulka M. Mast cell mediators: Their differential release and the secretory pathways involved. Frontiers in Immunology 2014;5(NOV):1\u201318. https:\/\/doi.org\/10.3389\/fimmu.2014.00569.","DOI":"10.3389\/fimmu.2014.00569"},{"issue":"2","key":"1179_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med. 2015;373(2):163\u201372. https:\/\/doi.org\/10.1056\/NEJMra1409760.","journal-title":"N Engl J Med"},{"issue":"7203","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature07204","volume":"454","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454(7203):445\u201354. https:\/\/doi.org\/10.1038\/nature07204.","journal-title":"Nature"},{"issue":"5","key":"1179_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jaci.2013.06.015","volume":"132","author":"SGA Brown","year":"2013","unstructured":"Brown SGA, Stone SF, Fatovich DM, et al. Anaphylaxis: Clinical patterns, mediator release, and severity. J Allergy Clin Immunol. 2013;132(5):1141-1149.e5. https:\/\/doi.org\/10.1016\/j.jaci.2013.06.015.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1179_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1542\/peds.106.4.762","volume":"106","author":"J Lee","year":"2000","unstructured":"Lee J, Greenes D. Biphasic anaphylactic reactions in pediatrics. Pediatrics. 2000;106(4):762\u20136.","journal-title":"Pediatrics"},{"issue":"3","key":"1179_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2500\/aap.2013.34.3654","volume":"34","author":"E Vezir","year":"2013","unstructured":"Vezir E, Erko\u00e7o\u011flu M, Kaya A, et al. Characteristics of anaphylaxis in children referred to a tertiary care center. Allergy Asthma Proc. 2013;34(3):239\u201346.","journal-title":"Allergy Asthma Proc"},{"issue":"1071","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/postgradmedj-2013-132181","volume":"91","author":"B Plumb","year":"2015","unstructured":"Plumb B, Bright P, Gompels MM, Unsworth DJ. Correct recognition and management of anaphylaxis: not much change over a decade. Postgrad Med J. 2015;91(1071):3\u20137. https:\/\/doi.org\/10.1136\/postgradmedj-2013-132181.","journal-title":"Postgrad Med J"},{"issue":"8","key":"1179_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/cea.12748","volume":"46","author":"RJ Mullins","year":"2016","unstructured":"Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46(8):1099\u2013110. https:\/\/doi.org\/10.1111\/cea.12748.","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","volume":"30","author":"RS Pumphrey","year":"2000","unstructured":"Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144\u201350. https:\/\/doi.org\/10.1046\/j.1365-2222.2000.00864.x.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"1179_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","volume":"133","author":"L Ma","year":"2014","unstructured":"Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(4):1075\u201383. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.029.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaip.2017.05.022","volume":"5","author":"W Alqurashi","year":"2017","unstructured":"Alqurashi W, Ellis AK. Do Corticosteroids Prevent Biphasic Anaphylaxis? The Journal of Allergy and Clinical Immunology. In Pract. 2017;5(5):1194\u2013205. https:\/\/doi.org\/10.1016\/j.jaip.2017.05.022.","journal-title":"In Pract"},{"key":"1179_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1081-1206(10)60861-7","volume":"98","author":"AK Ellis","year":"2007","unstructured":"Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol. 2007;98:64\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"1179_CR31","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1111\/all.12987","volume":"71","author":"GM Gauvreau","year":"2016","unstructured":"Gauvreau GM, Boulet L, Fitzgerald JM, et al. A dual CysLT 1 \/ 2 antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma. Allergy. 2016;71(12):1721\u20137. https:\/\/doi.org\/10.1111\/all.12987.","journal-title":"Allergy"},{"issue":"3","key":"1179_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1183\/13993003.00536-2015","volume":"46","author":"GM Gauvreau","year":"2015","unstructured":"Gauvreau GM, El-Gammal AI, O\u2019Byrne PM. Allergen-induced airway responses. Eur Respir J. 2015;46(3):819\u201331. https:\/\/doi.org\/10.1183\/13993003.00536-2015.","journal-title":"Eur Respir J"},{"issue":"1","key":"1179_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jemermed.2019.12.012","volume":"58","author":"S Bartholomew","year":"2020","unstructured":"Bartholomew S, Young A. Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort. J Emerg Med. 2020;58(1):172\u20133. https:\/\/doi.org\/10.1016\/j.jemermed.2019.12.012.","journal-title":"J Emerg Med"},{"issue":"5","key":"1179_CR34","doi-asserted-by":"publisher","first-page":"e35778","DOI":"10.1371\/journal.pone.0035778","volume":"7","author":"L Grabenhenrich","year":"2012","unstructured":"Grabenhenrich L, Hompes S, Gough H, et al. Implementation of anaphylaxis management guidelines: a register-based study. PLoS ONE. 2012;7(5):e35778. https:\/\/doi.org\/10.1371\/journal.pone.0035778.","journal-title":"PLoS ONE"},{"issue":"1","key":"1179_CR35","doi-asserted-by":"publisher","first-page":"CD001955","DOI":"10.1002\/14651858.CD001955.pub5","volume":"1","author":"A Aregbesola","year":"2023","unstructured":"Aregbesola A, Tam CM, Kothari A, Le ML, Ragheb M, Klassen TP. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023;1(1):CD001955. https:\/\/doi.org\/10.1002\/14651858.CD001955.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1179_CR36","doi-asserted-by":"publisher","first-page":"CD001955","DOI":"10.1002\/14651858.CD001955.pub4","volume":"8","author":"A Gates","year":"2018","unstructured":"Gates A, Gates M, Vandermeer B, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2018;8(8):CD001955. https:\/\/doi.org\/10.1002\/14651858.CD001955.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"1179_CR37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1398-9995.2010.02424.x","volume":"65","author":"KJ Choo","year":"2010","unstructured":"Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2010;65(10):1205\u201311. https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02424.x.","journal-title":"Allergy"},{"issue":"8","key":"1179_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/PEC.0000000000000864","volume":"32","author":"N Sidhu","year":"2016","unstructured":"Sidhu N, Jones S, Perry T, et al. Evaluation of Anaphylaxis Management in a Pediatric Emergency Department. Pediatric Emergency Care. 2016;32(8):508\u201313.","journal-title":"Pediatric Emergency Care"},{"issue":"3","key":"1179_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaci.2011.09.030","volume":"129","author":"RL Campbell","year":"2012","unstructured":"Campbell RL, Hagan JB, Manivannan V, et al. Evaluation of national institute of allergy and infectious diseases\/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012;129(3):748\u201352. https:\/\/doi.org\/10.1016\/j.jaci.2011.09.030.","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1081-1206(10)60227-X","volume":"101","author":"RL Campbell","year":"2008","unstructured":"Campbell RL, Luke A, Weaver AL, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol. 2008;101:631\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1179_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/ALN.0b013e318218119d","volume":"115","author":"L Garvey","year":"2011","unstructured":"Garvey L, Belhage B, Kroigaard M, Husum B, Malling H-J, Mosbech H. Treatment with Epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark. Anesthesiology. 2011;115(1):111\u20136.","journal-title":"Anesthesiology"},{"issue":"1","key":"1179_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaip.2013.08.012","volume":"2","author":"A Banerji","year":"2014","unstructured":"Banerji A, Rudders S, Clark S, Wei W, Long AA, Camargo CA. Retrospective Study of Drug-induced Anaphylaxis Treated in the Emergency Department or Hospital: Patient Characteristics, Management, and 1-Year Follow-up. J Allergy Clin Immunol: In Practice. 2014;2(1):46\u201351. https:\/\/doi.org\/10.1016\/j.jaip.2013.08.012.","journal-title":"J Allergy Clin Immunol: In Practice"},{"issue":"1 SUPPL.","key":"1179_CR43","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.amjmed.2013.09.008","volume":"127","author":"PL Lieberman","year":"2014","unstructured":"Lieberman PL. Recognition and first-line treatment of anaphylaxis. Am J Med. 2014;127(1 SUPPL.):S6\u201311. https:\/\/doi.org\/10.1016\/j.amjmed.2013.09.008.","journal-title":"Am J Med"},{"key":"1179_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0091-6749(94)70044-3","volume":"93","author":"DM Douglas","year":"1994","unstructured":"Douglas DM, Sukenick E, Andrade P, Brown J. Biphasic systemic anaphylaxis: An inpatient and outpatient study. J Allergy and Clin Immunol. 1994;93:977\u201385.","journal-title":"J Allergy and Clin Immunol"},{"issue":"6","key":"1179_CR45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/all.12404","volume":"69","author":"M Rohacek","year":"2014","unstructured":"Rohacek M, Edenhofer H, Bircher A, Bingisser R. Biphasic anaphylactic reactions: occurrence and mortality. Allergy. 2014;69(6):791\u20137. https:\/\/doi.org\/10.1111\/all.12404.","journal-title":"Allergy"},{"issue":"1","key":"1179_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.anai.2009.11.001","volume":"104","author":"R Confino-Cohen","year":"2010","unstructured":"Confino-Cohen R, Goldberg A. Allergen immunotherapy\u2013induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Ann Allergy Asthma Immunol. 2010;104(1):73\u20138. https:\/\/doi.org\/10.1016\/j.anai.2009.11.001.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1179_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000496092","volume":"179","author":"T-H Kim","year":"2019","unstructured":"Kim T-H, Yoon Soon H, Hong H, Kang H-R, Cho S-H, Lee S-Y. Duration of Observation for Detecting a Biphasic Reaction in Anaphylaxis: A Meta-Analysis. Int Arch Allergy Immunol. 2019;179(1):31\u20136. https:\/\/doi.org\/10.1159\/000496092.","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-024-01179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-024-01179-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-024-01179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:12:40Z","timestamp":1729059160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-024-01179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s11882-024-01179-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"28 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Matthew Giannetti receives funding from Blueprint medicines, Cogent biosciences, and Inmagene.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure Statement"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}